
inglés
Tecnología y ciencia
$99 / mes después de la prueba.Cancela cuando quieras.
Acerca de Let’s Talk Medtech
MD+DI editors discuss current trends in the medical device and diagnostics industry, and point out developments to watch in the coming months.
Shattering the Product Adoption Lie in the Medical Device Industry
Holley Miller [https://www.linkedin.com/in/holleymalia/], founder and President of Grey Matter Marketing, is our guest on this episode of Let's Talk Medtech to discuss why it's so crucial to have the right message for your product.
Let's Talk Women's Health in 2026
Join Marissa Fayer [https://www.linkedin.com/in/marissa-fayer/], CEO of HerHealthEQ [https://www.herhealtheq.org/] and DeepLook Medical, [https://www.deeplookmedical.com/] as she explores the future of women's health and what it could look like in 2026 in this insightful episode of Let's Talk Medtech.
Augurex Redefines Autoimmune Disease Detection
Augurex [https://augurex.com/] is a commercial-stage diagnostics company dedicated to the early identification and diagnosis of autoimmune disorders, enabling the optimization and personalization of treatment options for patients. Neil Klompas, the firm’s CEO, joins us for this episode of Let’s Talk Medtech to discuss how the company aims to accelerate the diagnosis of the disease and enhance autoimmune diagnostics for patients.
How Stereotaxis Is Making Its Mark in Surgical Robotics: A Journey from Survival to Success
Surgical robotics is changing the landscape in healthcare. Stereotaxis [https://www.stereotaxis.com/] is hoping to carve out its niche in the massive space, which is home to Intuitive Surgical, Johnson & Johnson, and Medtronic. David Fischel, the St. Louis, MO-based company’s chairman and CEO, is featured in this episode of Let’s Talk Medtech to discuss Stereotaxis’ journey from surviving to thriving. The firm recently secured $50 million in funding and has had strong collaborations with NVIDIA. Fischel talks about the company’s game plan and his thoughts on the future of surgical robotics.
Audacity Drives Innovation in Medtech
Audacity is defined as the willingness to take bold risks. It’s also a mantra for Lishan Aklog, MD, a co-founder and CEO PavMed [https://www.pavmed.com/], the parent company of Lucid Diagnostics [https://www.luciddx.com/]. Aklog makes his second appearance on Let’s Talk Medtech [https://www.mddionline.com/series/let-s-talk-medtech] to give updates on both companies and to discuss his philosophy on why audacity breeds innovation.
Elige tu suscripción
Más populares
Premium
20 horas de audiolibros
Podcasts solo en Podimo
Disfruta los shows de Podimo sin anuncios
Cancela cuando quieras
Empieza 7 días de prueba
Después $99 / mes
Empieza 7 días de prueba. $99 / mes después de la prueba. Cancela cuando quieras.